Peter K. Nielsen

Aa, 2760, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Interaction between Paracetamol Glucuronide and a Glucose-Sensitive Insulin Molecule (NNC2215): Increased Risk of Hypoglycemia.

Interaction between Paracetamol Glucuronide and a Glucose-Sensitive Insulin Molecule (NNC2215): Increased Risk of Hypoglycemia.

Journal: ACS pharmacology & translational science

Published: February 05, 2026

Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog.

Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog.

Journal: Journal of medicinal chemistry

Published: July 16, 2024

Multi-layered proteomics identifies insulin-induced upregulation of the EphA2 receptor via the ERK pathway which is dependent on low IGF1R level.

Multi-layered proteomics identifies insulin-induced upregulation of the EphA2 receptor via the ERK pathway which is dependent on low IGF1R level.

Journal: Scientific reports

Published: July 09, 2024

Glucose-sensitive insulin with attenuation of hypoglycaemia.

Glucose-sensitive insulin with attenuation of hypoglycaemia.

Journal: Nature

Published: May 01, 2023

Molecular Engineering of Efficacious Mono-Valent Ultra-Long Acting Two-Chain Insulin-Fc Conjugates.

Molecular Engineering of Efficacious Mono-Valent Ultra-Long Acting Two-Chain Insulin-Fc Conjugates.

Journal: Journal of medicinal chemistry

Published: February 01, 2022

Author Correction: Molecular engineering of safe and efficacious oral basal insulin.

Author Correction: Molecular engineering of safe and efficacious oral basal insulin.

Journal: Nature communications

Published: July 10, 2021

Correction: α2-Macroglobulin-like protein 1 can conjugate and inhibit proteases through their hydroxyl groups, because of an enhanced reactivity of its thiol ester.

Correction: α2-Macroglobulin-like protein 1 can conjugate and inhibit proteases through their hydroxyl groups, because of an enhanced reactivity of its thiol ester.

Journal: The Journal of biological chemistry

Published: April 10, 2021

Development of selective protease inhibitors via engineering of the bait region of human α2-macroglobulin.

Development of selective protease inhibitors via engineering of the bait region of human α2-macroglobulin.

Journal: The Journal of biological chemistry

Published: April 08, 2021

Structural Investigations of Human A2M Identify a Hollow Native Conformation That Underlies Its Distinctive Protease-Trapping Mechanism.

Structural Investigations of Human A2M Identify a Hollow Native Conformation That Underlies Its Distinctive Protease-Trapping Mechanism.

Journal: Molecular & cellular proteomics : MCP

Published: January 19, 2021

Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320.

Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320.

Journal: Journal of medicinal chemistry

Published: December 28, 2020

Substituting the Thiol Ester of Human A2M or C3 with a Disulfide Produces Native Proteins with Altered Proteolysis-Induced Conformational Changes.

Substituting the Thiol Ester of Human A2M or C3 with a Disulfide Produces Native Proteins with Altered Proteolysis-Induced Conformational Changes.

Journal: Biochemistry

Published: December 10, 2020

Characterization of Insulin Dimers by Top-Down Mass Spectrometry.

Characterization of Insulin Dimers by Top-Down Mass Spectrometry.

Journal: Journal of the American Society for Mass Spectrometry

Published: October 21, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026